Abstract
High-sensitivity C-reactive protein (hs-CRP) is a well-established biomarker of systemic inflammation and endothelial dysfunction. Its role in capturing inflammatory processes underlying migraine remains unclear. We aimed to determine whether serum hs-CRP levels are associated with migraine. This cross-sectional study enrolled adult participants with migraine and sex-matched healthy controls (HCs). Serum hs-CRP concentrations (mg/L) were measured using a validated assay. Participants with migraine were categorized into subgroups based on type (with aura, without aura, chronic, episodic) and headache status at sampling (ictal, interictal). The primary outcome was the percentage difference in serum hs-CRP concentrations between participants with migraine and HCs. Secondary outcomes included comparisons of hs-CRP levels across migraine subgroups and between each subgroup and HCs. Multivariate regression models were used to assess associations between hs-CRP and migraine after adjusting for age, sex, body mass index, and smoking status. Elevated hs-CRP levels were identified in adults with migraine, implicating low-grade inflammation in migraine pathogenesis. The online version contains supplementary material available at 10.1007/s10072-025-08738-y.
Keywords
Related Publications
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Background —Elevated plasma concentrations of C-reactive protein (CRP) are associated with increased cardiovascular risk. We evaluated whether long-term therapy with pravastatin...
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels
Background —We studied whether inflammation after myocardial infarction (MI) is a risk factor for recurrent coronary events and whether randomized treatment with pravastatin red...
Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients
Objective— Obesity is closely linked to the insulin resistance syndrome (IRS), type 2 diabetes, and cardiovascular disease, the primary cause of morbidity and mortality in these...
C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease
C-reactive protein (CRP)1 was discovered in 1930 by William Tillett and Thomas Francis from the Rockefeller University. They described a third serologic fraction, or “fraction C...
Lipoprotein-Associated Phospholipase A <sub>2</sub> , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
Background— Measuring C-reactive protein (CRP) has been recommended to identify patients at high risk for coronary heart disease (CHD) with low LDL cholesterol (LDL-C). Lipoprot...
Publication Info
- Year
- 2025
- Type
- book-chapter
- Pages
- 75-83
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1007/978-981-95-1818-0_9
- PMID
- 41402545
- PMCID
- PMC12708735